Discovery of Potent Disheveled/Dvl Inhibitors Using Virtual Screening Optimized With NMR-Based Docking Performance Index.

Hori, Kiminori; Ajioka, Kasumi; Goda, Natsuko; Shindo, Asako; Takagishi, Maki; Tenno, Takeshi; Hiroaki, Hidekazu

Hori, Kiminori; Ajioka, Kasumi; Goda, Natsuko; Shindo, Asako; Takagishi, Maki; Tenno, Takeshi; Hiroaki, Hidekazu.

Afiliación

Hori K; Laboratory of Structural Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya University, Nagoya, Japan.
Ajioka K; Department of Biological Science, School of Science, Nagoya University, Nagoya, Japan.
Goda N; Laboratory of Structural Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya University, Nagoya, Japan.
Shindo A; Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan.
Takagishi M; Department of Pathology, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
Tenno T; Laboratory of Structural Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya University, Nagoya, Japan.
Hiroaki H; BeCellBar LLC, Business Incubation Center, Nagoya University, Nagoya, Japan.

Front Pharmacol ; 9: 983, 2018.

Article en En | MEDLINE | ID: mdl-30233369

Palabras clave

NMR-derived docking performance index; Wnt signaling; proteinprotein interaction inhibitor; triple negative breast cancer; virtual screening

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Front Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google